12.2 Hereditary Ichthyoses & Disorders of Keratinisation

12.2 Hereditary Ichthyoses & Disorders of Keratinisation

Biology of Epidermal Differentiation & The Cornified Envelope

The hereditary ichthyoses constitute a heterogeneous group of Mendelian disorders of cornification characterised by generalised scaling of the skin due to defective epidermal differentiation, disrupted lipid barrier synthesis, or impaired corneodesmosomal desquamation.

The Molecular Architecture of Cornification

1. The Cornified Cell Envelope (CE): As keratinocytes ascend from the stratum spinosum into the stratum granulosum, intracellular structural proteins (involucrin, loricrin, envoplakin, and periplakin) are cross-linked at the inner plasma membrane by calcium-dependent transglutaminases, primarily Transglutaminase-1 (TGM1). Disruption of this cross-linking leads to severe structural fragility of the stratum corneum.
2. Profilaggrin and Keratohyalin Granules: Keratohyalin granules in the stratum granulosum store profilaggrin, a giant polyprotein precursor. During terminal differentiation, profilaggrin is dephosphorylated and cleaved into 10–12 functional filaggrin (FLG) monomers. Filaggrin aggregates keratin intermediate filaments (K1 and K10) into dense, parallel macrofibrils, causing cell flattening into anucleated corneocytes. Subsequently, filaggrin is enzymatically degraded into free amino acids (including glutamine, histidine, and urocanic acid), which constitute the Natural Moisturising Factor (NMF) responsible for stratum corneum hydration and acidic pH regulation.
3. The Lipid Lamellar Bilayer: Membrane-bound organelles termed lamellar bodies (Odland bodies) store glucosylceramides, sphingomyelin, cholesterol, and phospholipids. Regulated by ATP-binding cassette transporters (ABCA12) and lipoxygenases (ALOX12B, ALOXE3), these lipids are extruded into the intercellular space to form the hydrophobic lipid lamellar sheets that coat the cornified envelope, creating the primary physical permeability barrier.
4. Desquamation Kinetics: In normal skin, desquamation is mediated by kallikrein-related serine proteases (KLK5, KLK7) that degrade corneodesmosomes (desmoglein 1, desmocollin 1, corneodesmosin). This enzymatic degradation is strictly regulated by the serine protease inhibitor LEKTI (encoded by SPINK5, mutated in Netherton syndrome).

---

Ichthyosis Vulgaris (IV)

Ichthyosis vulgaris (IV) is the most common disorder of cornification, affecting approximately 1 in 100 to 1 in 250 individuals in European populations.

Molecular Genetics

• Inheritance: Autosomal semidominant with incomplete penetrance. Heterozygous individuals exhibit a mild-to-moderate phenotype, whereas homozygous or compound heterozygous individuals demonstrate severe, persistent ichthyosis.
• Gene Defect: Loss-of-function mutations in the FLG gene (chromosome 1q21.3) within the Epidermal Differentiation Complex. In European populations, two ancestral null mutations (R501X and 2282del4) account for approximately 80% of mutation alleles.

Clinical Presentation

• Onset: Never present at birth. Scaling typically becomes apparent between 3 and 12 months of age.
• Cutaneous Morphology: Fine, delicate, polygonal, light-white to grey scales with free superficial edges. Most prominent on the extensor surfaces of the extremities (shins, forearms) and trunk.
• Flexural Sparing: Characteristically spares the flexural creases (axillae, antecubital fossae, popliteal fossae, groin), where elevated relative humidity and temperature compensate for the natural moisturising factor deficiency.
• Associated Hallmarks:
  • Palmar Hyperlinearity: Pronounced, deep, accentuated creases on the palms and soles, present in over 90% of patients.
  • Keratosis Pilaris: Spiny follicular keratotic papules on the lateral upper arms, anterior thighs, and cheeks.
  • Atopic Diathesis: Up to 50% of patients with IV suffer from atopic dermatitis, allergic rhinitis, food allergies, or asthma. FLG null mutations represent the single strongest known genetic risk factor for atopic eczema and the "atopic march" due to epidermal barrier breakdown permitting percutaneous antigen penetration.

Histopathology

• Compact orthohyperkeratosis.
• Marked reduction or complete absence of the stratum granulosum (loss of keratohyalin granules under light microscopy; diagnostic hallmark).
• Electron microscopy demonstrates small, structurally abnormal, crumbly keratohyalin granules.

---

X-Linked Recessive Ichthyosis (XLRI)

X-Linked Recessive Ichthyosis (XLRI) affects approximately 1 in 6,000 males, caused by an inborn error of lipid metabolism.

Molecular Genetics & Pathogenesis

• Inheritance: X-linked recessive (manifests in males; females are typically asymptomatic carriers).
• Gene Defect: Deletion or loss-of-function mutation in the STS gene (chromosome Xp22.31) encoding steroid sulfatase (arylsulfatase C). Approximately 85% to 90% of cases are caused by large submicroscopic contiguous microdeletions of Xp22.31.
• Pathophysiology: Steroid sulfatase hydrolyses cholesterol sulfate into free cholesterol within the stratum corneum. In STS deficiency, cholesterol sulfate accumulates 10- to 30-fold in the epidermis. Elevated cholesterol sulfate inhibits kallikrein (serine protease)-mediated desquamation, stabilizing corneodesmosomes and causing failure of corneocyte detachment (retention hyperkeratosis).

Clinical Presentation

• Onset: Present at birth or emerges within the first 3 months of life (present earlier than ichthyosis vulgaris).
• Cutaneous Morphology: Large, thick, polygonal, adherent dark brown or grey scales that produce a characteristic "dirty" appearance.
• Distribution: Generalized involvement covering the trunk, abdomen, and limbs. A pathognomonic sign is prominent involvement of the lateral neck ("dirty neck syndrome") and preauricular facial skin. Flexural creases (antecubital/popliteal) may show mild involvement. Palms and soles are strictly spared (no hyperlinearity).

Obstetric & Extracutaneous Hallmarks

• Obstetric History (Failure of Labor Progression): Placental steroid sulfatase deficiency prevents the hydrolysis of fetal dehydroepiandrosterone sulfate (DHEA-S) into free estrogens (estrone and estradiol). The resulting profound drop in maternal estriol produces uterine inertia and failure of cervical dilation, leading to prolonged, non-progressing labor requiring emergency Caesarean section.
• Corneal Opacities: Asymptomatic, deep stromal comma-shaped or dot-like corneal opacities located in the deep corneal stroma near Descemet membrane, detectable by slit-lamp examination in 50% of adult males and many carrier females. They do not impair vision but represent a diagnostic gold standard.
• Cryptorchidism & Testicular Dysgerminoma: Unilateral or bilateral undescended testes occur in up to 20% of males, conferring an increased lifetime risk of testicular germ cell tumors independent of surgical orchidopexy.
• Contiguous Gene Deletion Syndromes: Microdeletions extending beyond STS on Xp22.31 can involve adjacent genes, producing complex syndromic phenotypes: deletion of KAL1 produces Kallmann syndrome (hypogonadotropic hypogonadism and anosmia); deletion of VCX-A produces intellectual disability; deletion of SHOX produces short stature and Léri-Weill dyschondrosteosis.

Histopathology

• Massive, compact orthohyperkeratosis with a normal or thickened stratum granulosum (readily distinguishing XLRI from ichthyosis vulgaris).

---

Autosomal Recessive Congenital Ichthyosis (ARCI)

Autosomal Recessive Congenital Ichthyosis (ARCI) encompasses a spectrum of severe non-syndromic disorders of cornification with a birth prevalence of ~1 in 100,000, unified by autosomal recessive inheritance and frequent presentation as a collodion baby.

1. The Collodion Baby Presentation

Approximately 80% of neonates who eventually develop ARCI are born encased in a collodion membrane:

• Clinical Appearance: The newborn is encased in a taut, shiny, glistening, yellowish membrane resembling oiled parchment or sausage casing. Mechanical traction causes severe ectropion (eversion of eyelids), eclabium (eversion of lips), crumpled flattened external ears, and pseudosyndactyly of digits.
• Acute Neonatal Risks: Massive transepidermal water loss (TEWL) leading to hypernatremic dehydration, failure of thermoregulation (severe hypothermia), cutaneous fissures serving as portals of entry for systemic sepsis (Staphylococcus aureus, Pseudomonas aeruginosa), and restricted thoracic excursion causing mechanical respiratory failure.
• Outcome: The collodion membrane cracks, fissures, and desquamates over 2 to 4 weeks. While about 10% evolve into "self-healing collodion baby" (usually with temperature-sensitive or other hypomorphic variants in TGM1, ALOX12B, or ALOXE3), the vast majority develop lifelong Lamellar Ichthyosis or Non-bullous Congenital Ichthyosiform Erythroderma.

2. Lamellar Ichthyosis (LI)

• Molecular Genetics: Caused primarily by homozygous or compound heterozygous mutations in TGM1 (chromosome 14q11.2, encoding transglutaminase-1, the most common cause of classical LI). Other genes include NIPAL4, ALOX12B, ABCA12, and CYP4F22.
• Clinical Presentation: Minimal or absent underlying erythroderma. The entire cutaneous surface is covered by large, thick, dark brown or black plate-like scales arranged in a quadripartite or mosaic pattern resembling reptilian skin. Scale prominently involves the flexural creases.
• Complications: Severe, persistent cicatricial ectropion (risking exposure keratitis), cicatricial alopecia, palmar/plantar hyperkeratosis, and severe hypohidrosis (occlusion of eccrine sweat ducts by compact hyperkeratosis, predisposing to heat exhaustion and life-threatening heat stroke during physical exertion or warm ambient temperatures).

3. Non-Bullous Congenital Ichthyosiform Erythroderma (NCIE)

• Molecular Genetics: Heterogeneous; caused by mutations in ALOX12B (12R-lipoxygenase), ALOXE3 (epidermal lipoxygenase-3), CYP4F22, NIPAL4 (ichthyin), or ABCA12.
• Clinical Presentation: Marked, generalized, persistent erythroderma accompanied by fine, white-to-light-brown, superficial, flaky scales. Unlike lamellar ichthyosis, erythroderma is the dominant feature, and scales are delicate rather than thick/plate-like.
• Associated Features: Ectropion is less severe than in LI; palmar and plantar keratoderma, severe heat intolerance, and intense pruritus are common.

4. Harlequin Ichthyosis (HI)

• Molecular Genetics: Autosomal recessive; caused by homozygous or compound heterozygous null (nonsense, frameshift) mutations in the ABCA12 gene (chromosome 2q35). ABCA12 encodes a transmembrane ATP-binding cassette transporter essential for transporting glucosylceramides and lipids into epidermal lamellar bodies.
• Clinical Presentation: The most severe and historically fatal form of congenital ichthyosis. The neonate is encased in an impenetrable, thick, armor-like shell of keratin divided into massive diamond-shaped and polygonal hyperkeratotic plates by deep, raw, bleeding fissures.
• Extreme Morbid Anatomy: Severe bilateral ectropion (complete conjunctival chemosis obscuring globes), severe eclabium (lips tethered open), absent/rudimentary external ears, flattened nasal bridge, and claw-like ischemic contractures of extremities.
• Modern Survival: Historically lethal within days due to respiratory failure, dehydration, or fulminant sepsis. Survival has risen above 80% with immediate NICU supportive care and early initiation of oral acitretin (0.5–1 mg/kg/day), which accelerates shedding of the armor plates over several weeks into a severe generalized erythrodermic ichthyosis phenotype.

---

Epidermolytic Ichthyosis (EI / Bullous Congenital Ichthyosiform Erythroderma)

Epidermolytic ichthyosis (EI), previously designated bullous congenital ichthyosiform erythroderma of Brocq, affects approximately 1 in 200,000 to 300,000 individuals.

Molecular Genetics & Pathogenesis

• Inheritance: Autosomal dominant; approximately 50% of cases arise from de novo spontaneous mutations.
• Gene Defect: Heterozygous dominant-negative mutations in KRT1 (chromosome 12q13) or KRT10 (chromosome 17q21). Keratins 1 and 10 form the intermediate filament heterodimer cytoskeleton of suprabasal (spinous and granular layer) epidermal keratinocytes. Point mutations disrupt filament assembly, destabilizing the cytoskeleton and causing suprabasal cellular collapse and cytolysis upon mechanical stress.

Dynamic Natural History & Biphasic Phenotype

1. Neonatal Phase (Blistering & Erythroderma): At birth and during early infancy, the infant presents with generalised erythroderma, superficial flaccid blistering, and widespread denuded erosions mimicking Epidermolysis Bullosa or Staphylococcal Scalded Skin Syndrome (SSSS). Skin fragility (positive Nikolsky sign) is prominent.
2. Childhood & Adult Phase (Spiny Verrucous Hyperkeratosis): As the child ages, blister frequency dramatically declines, replaced by progressive, severe, generalized verrucous, spiny, or corrugated dark brown/grey hyperkeratosis. The hyperkeratosis forms thick, rippled ridges with a predilection for the flexural creases (axillae, antecubital and popliteal fossae, neck, groin). Secondary bacterial colonization by Staphylococcus aureus and Corynebacterium imparts a distinctive, pungent, foul odor.

KRT1 vs. KRT10 Phenotypic Divergence

• KRT1 Mutations: Involve the palms and soles, producing severe epidermolytic palmoplantar keratoderma (PPK). Keratin 1 pairs with Keratin 9 in palmar/plantar epidermis; thus, defective KRT1 disrupts both glabrous and non-glabrous skin.
• KRT10 Mutations: Strictly spare the palms and soles (no PPK). Keratin 9 compensates for the defective KRT10 in suprabasal palmoplantar epidermis.

Histopathology: Epidermolytic Hyperkeratosis

• Marked compact orthohyperkeratosis.
• Vacuolar degeneration (cytolysis) of suprabasal keratinocytes in the stratum spinosum and stratum granulosum, without true acantholysis.
• Large, dense, irregular, clumped keratohyalin granules under light microscopy, corresponding to collapsed keratin intermediate filament bundles on electron microscopy.

---

Neonatal Management of the Collodion Baby

The birth of a collodion baby constitutes a dermatological and paediatric emergency requiring immediate admission to a Level III Neonatal Intensive Care Unit (NICU):

NICU Environmental and Supportive Protocol

1. High-Humidity Microenvironment: Place the infant in a humidified incubator with relative humidity maintained at 80% to 90%, gradually weaning as the membrane sheds. This suppresses evaporative fluid loss, reduces metabolic demand, and stabilises body temperature.
2. Thermoregulation: Prevent hypothermia through ambient incubator warming; radiant warmers should be avoided if possible as radiant heat accelerates evaporative dehydration.
3. Fluid and Electrolyte Balance: Frequent serum electrolyte monitoring (every 12–24 hours). Due to extreme TEWL, fluid requirements may reach 150 to 200 mL/kg/day to prevent hypernatremic dehydration and prerenal acute kidney injury.
4. Sterile Barrier Protection: Meticulous aseptic handling, protective isolation, and regular skin swabs. Sepsis is the leading cause of early mortality.
5. Topical Barrier Therapy: Liberal, frequent (every 2–4 hours) application of sterile, bland, non-medicated petrolatum-based emollients (50% white soft paraffin / 50% liquid paraffin). Fissures may be dressed with soft silicone contact layers.
6. Ophthalmologic Care: Intensive eye lubrication with preservative-free artificial tears and bland ophthalmic ointment every 1–2 hours to prevent corneal desiccation and exposure keratitis secondary to ectropion.

Critical Management Prohibitions (Board Traps!)

• NO Topical Keratolytics: Salicylic acid, urea, alpha-hydroxy acids, and propylene glycol are strictly contraindicated due to rapid percutaneous absorption across the incompetent epidermal barrier, risking fatal systemic intoxication.
• NO Early Systemic Retinoids: Oral acitretin is contraindicated during the initial collodion phase. Retinoids accelerate membrane desquamation, precipitating massive, acute de-epithelialisation, fluid shock, and fulminant systemic sepsis. (Harlequin ichthyosis is the sole exception where early acitretin is initiated under strict NICU conditions).
• NO Mechanical Debridement: Never peel or pull the collodion membrane forcibly; spontaneous shedding must occur naturally to avoid deep dermal tears.

---

Dermatopharmacology & Toxicology in Keratinisation Disorders

1. Topical Keratolytic Agents & Transcutaneous Poisoning

• Salicylic Acid (Beta-Hydroxy Acid): Solubilizes intercellular cement. Contraindicated in neonates, infants, and extensive ichthyoses. Percutaneous absorption leads to salicylism: tachypnea, severe metabolic acidosis, tinnitus, delirium, convulsions, and death.
• Urea (Carbamide): Natural hydrating agent and keratolytic at concentrations >10%. Contraindicated in neonates and young infants due to transcutaneous absorption causing raised blood urea (uraemia) and systemic toxicity; causes severe stinging on excoriated skin.
• Alpha-Hydroxy Acids (Lactic Acid, Glycolic Acid): Disrupts corneocyte cohesion. Extensive application in small children can induce systemic lactic acidosis and severe local irritation.
• Propylene Glycol: Enhances keratolytic penetration; when applied extensively under occlusion, percutaneous absorption causes hyperosmolality, lactic acidosis, and central nervous system depression.

2. Systemic Retinoids (Acitretin)

• Indications: Severe ARCI (Lamellar Ichthyosis, refractory NCIE) and Harlequin Ichthyosis.
• Dosing in Paediatrics: Initial dose 0.25 to 0.5 mg/kg/day, titrating to a maintenance dose of 0.5 to 1.0 mg/kg/day.
• Special Caution in Epidermolytic Ichthyosis: Acitretin must be used with extreme caution at very low starting doses (0.1 mg/kg/day) in EI. Standard doses induce massive stratum corneum peeling, uncovering the fragile suprabasal epidermis and triggering catastrophic, widespread blistering.
• Monitoring & Paediatric Skeletal Toxicity: Long-term administration in growing children carries a risk of premature epiphyseal closure, diffuse idiopathic skeletal hyperostosis (DISH)-like calcifications of ligaments, periosteal thickening, and osteoporosis. Monitor growth and bone symptoms, with targeted radiographs periodically during long-term treatment.
• Teratogenicity & Contraception: Absolute teratogen. Strict pregnancy prevention during treatment and for 3 full years following treatment cessation due to reverse metabolic esterification of acitretin to etretinate (which possesses an exceptionally prolonged elimination half-life of 120 days).

---

Master Comparative Matrix: The Hereditary Ichthyoses